Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.
about
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialA robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinomaSignatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancerCopy number variation analysis of matched ovarian primary tumors and peritoneal metastasisIntegrative genomics in combination with RNA interference identifies prognostic and functionally relevant gene targets for oral squamous cell carcinoma.Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasisMutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.The role of high-throughput technologies in clinical cancer genomics.Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation.Molecular Concordance Between Primary Breast Cancer and Matched Metastases.Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.Discordant Mutations in Paired Primary and Metastatic Endometrial Adenocarcinomas Identified by Semiconductor-Based Sequencing for Rapid Cancer Genotyping.The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy.Bone metastases: assessment, management and treatment options.Evolution of early phase clinical trials in oncology.Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.Survival of breast cancer patients according to changes in expression of selected markers between primary tumor and lymph node metastases.
P2860
Q26782613-8E9538A8-2439-4CF8-9E14-93BCFF6C5EC2Q28385552-72D4961B-9653-4148-AF81-4DA9E06CB043Q28389284-E34F029C-7AEA-4D7C-B93D-60853A199C46Q34110125-2200C95F-29BF-4958-910A-B788E94B011FQ34558023-FC0CF114-2320-4B14-8B9D-E96DC07EB915Q35742371-83D92272-4393-4E96-BBA9-C5B699150FDFQ35836960-093532C5-1F40-437F-9AB8-B16E3E941DB1Q37373790-5A29F29D-9605-47C2-85B4-A78FC22C6FC4Q38088010-2041AF58-B81D-4261-8E07-7B63CDCF05DAQ38184989-9095DDEC-F548-498C-853F-C8AA5791E787Q38810954-FAFC99BB-672F-4E43-B16E-B3362175B510Q39086320-5AFD68FC-B7FD-4D04-8B9A-0919A02CF286Q39773144-EDC80180-A905-4BDA-AC0A-63CC02F1A4D3Q41673084-79733659-DC4A-496A-94CE-09805D47FB2BQ44563830-C8BB69C5-E323-408C-AAB8-079468182107Q47816379-47685CEA-A25F-401F-B09D-B7A13CFB997CQ50720110-040FEC1A-BA40-48DA-984B-980BE4861E9FQ50954857-46331EF3-2650-4F73-A8F5-644640D62FCBQ53635504-4081C822-0865-4FFB-B339-9918919566FD
P2860
Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Frequent genetic differences b ...... rkers for disease progression.
@ast
Frequent genetic differences b ...... rkers for disease progression.
@en
Frequent genetic differences b ...... rkers for disease progression.
@nl
type
label
Frequent genetic differences b ...... rkers for disease progression.
@ast
Frequent genetic differences b ...... rkers for disease progression.
@en
Frequent genetic differences b ...... rkers for disease progression.
@nl
prefLabel
Frequent genetic differences b ...... rkers for disease progression.
@ast
Frequent genetic differences b ...... rkers for disease progression.
@en
Frequent genetic differences b ...... rkers for disease progression.
@nl
P2093
P2860
P50
P356
P1476
Frequent genetic differences b ...... rkers for disease progression.
@en
P2093
Andrzej B Popławski
Aneta Kaczmarczyk
Barbara Zegarska
Carl Eg Bruder
Chiquito Crasto
Dariusz Bała
E Christopher Partridge
Ewa Srutek
Jingyu Guo
Johanna Sandgren
P2860
P2888
P304
P356
10.1038/EJHG.2009.230
P577
2010-01-06T00:00:00Z